Layer 7 Cortical Interface for Paralysis
Communication & Device Control for Paralysis (e.g., spinal cord injury, ALS)
Feasibility/Clinical ResearchActive
Key Facts
Indication
Communication & Device Control for Paralysis (e.g., spinal cord injury, ALS)
Phase
Feasibility/Clinical Research
Status
Active
Company
About Precision Neuroscience
Precision Neuroscience, founded in 2021, is a private, clinical-stage medical device company pioneering a less invasive approach to brain-computer interfaces. Its flagship technology, the Layer 7 Cortical Interface, is a thin-film electrode array that conforms to the brain's surface and has achieved FDA clearance and a record for electrode density in humans. The company is advancing through clinical research with major academic medical centers, has secured significant venture funding, and is building in-house manufacturing capability, positioning it as a leading competitor in the emerging high-bandwidth BCI market.
View full company profile